Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20050059750 A1
Publication typeApplication
Application numberUS 10/935,510
Publication dateMar 17, 2005
Filing dateSep 7, 2004
Priority dateJun 1, 1993
Also published asCA2162927C, DE9490446U1, DE69413395D1, DE69413395T2, DE69425838D1, DE69425838T2, DE69434462D1, DE69434462T2, EP0701453A1, EP0701453B1, EP0847765A1, EP0847765B1, EP1005872A1, EP1005872B1, EP1598086A2, US5414049, US5449745, US5543471, US5650485, US5728748, US6174934, US6372814, US6664308, US6818020, US20020107299, US20030207957, WO1994027651A1
Publication number10935510, 935510, US 2005/0059750 A1, US 2005/059750 A1, US 20050059750 A1, US 20050059750A1, US 2005059750 A1, US 2005059750A1, US-A1-20050059750, US-A1-2005059750, US2005/0059750A1, US2005/059750A1, US20050059750 A1, US20050059750A1, US2005059750 A1, US2005059750A1
InventorsDeh-Chuan Sun, Casper Stark
Original AssigneeHowmedica Osteonics Corp.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Non-oxidizing polymeric medical implant
US 20050059750 A1
Abstract
A medical implant made of polymeric material having an increased oxidation resistance is formed by a method including the steps of placing a resin powder in a sealed container. A substantial portion of the oxygen is removed from the sealed contained by either a vacuum, an oxygen absorbent or by flushing with inert gas. The container is then repressurized with a gas such as nitrogen, argon, helium or neon so that long term storage may be possible. On use, the resin in transferred to a forming device which both melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material such as a rod or bar stock. The medical implant is then formed from this raw material annealed and sealed in an airtight package in an oxygen reduced atmosphere. The implant is then radiation sterilized and thereafter annealed in the package for a predetermined time and temperature sufficient to form cross-links between any free radicals in neighboring polymeric chains.
Images(8)
Previous page
Next page
Claims(19)
1. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 and having a FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging at 80° C. for up to 11 days.
2. The polyethylene as set forth in claim 1 wherein the FTIR oxidation index of the polyethylene does not increase with oven aging in air at 80° C. for up to 23 days.
3. The polyethylene as set forth in claim 1 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
4. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000, a solubility of less than 80.9% in trichlorobenzene and an oxidation index which does not increase during oven aging in air at 80° C. for up to 11 days.
5. The polyethylene as set forth in claim 4 wherein the level of free radicals is 1.0×1017/gram or less.
6. The polyethylene as set forth in claim 4 wherein the FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index does not increase with oven aging in air at 80° C. for up to 23 days.
7. The polyethylene as set forth in claim 4 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
8. The polyethylene as set forth in claim 4 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%
9. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 and a solubility of less than 80.9% in 1,2,4-trichlorobenzene.
10. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the level of free radicals in the polyethylene is 1.0×1017/gram or less.
11. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the polyethylene has a FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging in air at 80° C. for up to 11 days.
12. The irradiated ultra-high molecular weight polyethylene as set forth in claim 9 wherein the polyethylene has an FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging in air at 80° C. for up to 23 days.
13. An irradiated ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 wherein the level of free radicals is 1.0×1017/gram or less and an oxidation index which does not increase during oven aging in air at 80° C. for 11 days.
14. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at temperature greater than 25° C. for a sufficient time to have a solubility of less than 80.9% in trichlorobenzene and a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index during oven aging in air at 80° C. for up to 11 days.
15. The polyethylene as set forth in claim 14 wherein the FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index does not increase with oven aging in air at 80° C. for up to 23 days.
16. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a level of free radicals of 1.0×1017/gram or less and an oxidation index which does not increase during oven aging in air at 80° C. for 11 days.
17. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index of 0.01 during oven aging in air at 80° C. for 11 days.
18. An ultra-high molecular weight polyethylene having a weight average molecular weight greater than 400,000 irradiated and annealed at a temperature greater than 25° C. for a sufficient time to have a non-increasing FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index of 0.01 or less during oven aging in air at 80° C. for 11 days and a solubility of less than 80.9% in trichlorobenzene.
19. The polyethylene as set forth in claim 14 wherein the weight percent of the polyethylene having a molecular weight below 100,000 is less than 18.4%.
Description
    CROSS-REFERENCE TO RELATED APPLICATIONS
  • [0001]
    This application is a divisional of U.S. Ser. No. 10/461,636 filed Jun. 13, 2003 which is a continuation of U.S. Ser. No. 10/041,118 filed Jan. 8, 2002 which is a continuation of U.S. Pat. No. 6,372,814 which is a continuation of U.S. Pat. No. 6,174,934, which is a continuation of U.S. Ser. No. 733,067 filed Oct. 16, 1996, U.S. Pat. No. 5,728,748, which is a continuation of U.S. Ser. No. 439,028 filed May 11, 1995, U.S. Pat. No. 5,650,485, which is a division of U.S. Ser. No. 320,705 filed Oct. 7, 1994, U.S. Pat. No. 5,449,745 which is a division of U.S. Ser. No. 08/070,074 filed Jun. 1, 1993, U.S. Pat. No. 5,414,049.
  • BACKGROUND OF THE INVENTION
  • [0002]
    This invention relates to medical implants formed of a polymeric material such as ultra-high molecular weight polyethylene, with superior oxidation resistance upon irradiation and a method for making the same.
  • [0003]
    Various polymer systems have been used for the preparation of artificial prostheses for biomedical use, particularly orthopedic applications. Among them, ultra-high molecular weight polyethylene is widely used for articulation surfaces in artificial knee and hip replacements. Ultra-high molecular weight polyethylene (UHMWPE) has been defined as those linear polyethylenes which have a relative viscosity of 2.3 or greater at a solution concentration of 0.05% at 135° C. in decahydronaphthalene. The nominal weight—average molecular weight is at least 400,000 and up to 10,000,000 and usually from three to six million. The manufacturing process begins with the polymer being supplied as fine powder which is consolidated into various forms, such as rods and slabs, using ram extrusion or compression molding. Afterwards, the consolidated rods or slabs are machined into the final shape of the orthopedic implant components. Alternatively, the component can be produced by compression molding of the UHMWPE resin powder.
  • [0004]
    All components must then go through a sterilization procedure prior to use, but usually after being packaged. There exists several sterilization methods which can be utilized for medical applications, such as the use of ethylene oxide, heat, or radiation. However, applying heat to a packaged polymeric medical product can destroy either the integrity of the packaging material (particularly the seal, which prevents bacteria from going into the package after the sterilization step) or the product itself.
  • [0005]
    Because ethylene oxide may adversely impact environmental and employee safety, gamma ray, x-ray or electron beam radiation has been utilized as a preferred means of sterilization. These types of radiation use a high energy beam to kill bacteria, viruses, or other microbial species contained in the packaged medical products, achieving the goal of product sterility.
  • [0006]
    However, it has been recognized that regardless of the radiation type, the high energy beam causes generation of free radicals in polymers during radiation. It has also been recognized that the amount of free radicals generated is dependent upon the radiation dose received by the polymers and that the distribution of free radicals in the polymeric implant depends upon the geometry of the component, the type of polymer, the dose rate, and the type of radiation beam. The generation of free radicals can be described by the following reaction (which uses polyolefin and gamma ray irradiation for illustration):
  • [0007]
    Depending whether or not oxygen is present, primary free radicals r˜ will react with oxygen and the polymer according to the following reactions as described in “Radiation Effects on Polymers”, edited by Roger L. Clough and Shalaby W. Shalaby, published by American Chemical Society, Washington, D.C., 1991.
  • [0008]
    In the presence of oxygen
  • [0009]
    In radiation in air, primary free radicals r. will react with oxygen to form peroxyl free radicals r02., which then react with polyolefin (such as UHMWPE) to start the oxidative chain scission reactions (reactions 2 through 6). Through these reactions, material properties of the plastic, such as molecular weight, tensile, and wear properties, are degraded.
  • [0010]
    Recently, it was found that the hydroperoxides (rOOH and POOH) formed in reactions 3 and 5 will slowly break down as shown in reaction 7 to initiate post-radiation degradation. Reactions 8 and 9 represent termination steps of free radicals to form ester or carbon-carbon cross-links. Depending on the type of polymer, the extent of reaction 8 and 9 in relation to reactions 2 through 7 may vary. For irradiated UHMWPE, a value of 0.3 for the ratio of chain scission to cross-linking has been obtained, indicating that even though cross-linking is a dominant mechanism, a significant amount of chain scission occurs in irradiated polyethylene.
  • [0011]
    By applying radiation in an inert atmosphere, since there is no oxidant present, the primary free radicals r. or secondary free radicals P. can only react with other neighboring free radicals to form carbon-carbon cross-links, according to reactions 10 through 12 below. If all the free radicals react through reactions 10 through 12, there will be no chain scission and there will be no molecular weight degradation. Furthermore, the extent of cross-linking is increased over the original polymer prior to irradiation. On the other hand, if not all the free radicals formed are combined through reactions 10, 11 and 12, then some free radicals will remain in the plastic component.
  • [0012]
    In an Inert Atmosphere
    r.+polyolefin - - - P.  (10)
    2 r. - - - r-r (C—C cross-linking)  (11)
    2 P. - - - P—P (C—C cross-linking)  (12)
  • [0013]
    It is recognized that the fewer the free radicals, the better the polymer retains its physical properties over time. The greater the number of free radicals, the greater the degree of molecular weight and polymer property degradation will occur. Applicant has discovered that the extent of completion of free radical cross-linking reactions is dependent on the reaction rates and the time period given for reaction to occur.
  • [0014]
    Several prior art patents attempt to provide methods which enhance UHMWPE physical properties. European Patent Application 0 177 522 81 discloses UHMWPE powders being heated and compressed into a homogeneously melted crystallized morphology with no grain memory of the UHMWPE powder particles and with enhanced modulus and strength. U.S. Pat. No. 5,037,928 discloses a prescribed heating and cooling process for preparing a UHMWPE exhibiting a combination of properties including a creep resistance of less than 1% (under exposure to a temperature of 23° C. and a relative humidity of 50% for 24 hours under a compression of 1000 psi) without sacrificing tensile and flexural properties. U.K. Patent Application GB 2 180 815 A discloses a packaging method where a medical device which is sealed in a sterile bag, after radiation/sterilization, is hermetically sealed in a wrapping member of oxygen-impermeable material together with a deoxidizing agent for prevention of post-irradiation oxidation.
  • [0015]
    U.S. Pat. No. 5,153,039 relates to a high density polyethylene article with oxygen barrier properties. U.S. Pat. No. 5,160,464 relates to a vacuum polymer irradiation process.
  • SUMMARY OF THE INVENTION
  • [0016]
    The present invention relates to a method for providing a polymeric material, such as UHMWPE, with superior oxidation resistance upon irradiation. For the purpose of illustration, UHMWPE will be used as an example to describe the invention. However, all the theories and processes described hereafter should also apply to other polymeric materials such as polypropylene, high density polyethylene, polyester, nylon, polyurethane and poly(methylmethacrylate) unless otherwise stated.
  • [0017]
    As stated above, while UHMWPE polymer is very stable and has very good resistance to aggressive media except for strong oxidizing acids. Upon sterilization radiation, free radicals are formed which cause UHMWPE to become activated for chemical reactions and physical changes. Possible chemical reactions include reacting with oxygen, water, body fluids, and other chemical compounds while physical changes include density, crystallinity, color, and other physical properties. In the present invention a new sterilization radiation process greatly reduces the adverse effects caused by a conventional radiation process. Furthermore, this new sterilization process does not employ stabilizers, antioxidants, or any other chemical compounds which may have potential adverse effects in biomedical or orthopedic applications.
  • [0018]
    In the sterilization process of the present invention, a polymeric orthopedic implant component to be sterilized by radiation does not contain oxidants, such as oxygen or water (or moisture), or free radicals. This may be accomplished by obtaining a raw material for the implant manufactured under a special process as described herein and forming a part of the invention.
  • [0019]
    The finished polymeric orthopedic component is then sealed in an oxidant-free atmosphere. This oxidant-free atmosphere is maintained during radiation. The radiated polymeric component is then subjected to a heat treatment to cross-link all the free radicals within themselves. During this treatment, the condition of oxidant-free atmosphere is maintained. The irradiated, heat treated plastic component is now ready to use. Exposure to oxygen or moisture will not cause oxidation. The oxidation resistance to any oxidizing agent is similar to that of the unirradiated virgin polymer.
  • [0020]
    It is therefore an object of the invention to provide a polymeric orthopedic implant having superior oxidation resistance after irradiation.
  • [0021]
    It is still another object of the invention to provide a method for manufacturing such an implant from the resin powder thereof through the final sterilization step so that the implant may thereafter be exposed to air without degradation due to oxidation.
  • [0022]
    These and other objects are achieved by a method for producing a polymeric medical implant including the steps of placing the polymeric resin in a sealed container and removing a substantial portion of the oxygen from the container. After a predetermined time, the container is repressurized with an inert gas such as nitrogen, argon, helium or neon. The resin is thereafter transferred to a forming device which normally melts and forms the resin in an oxygen reduced atmosphere to produce a polymeric raw material. The polymeric raw material, such as UHMWPE is then machined to an implant such as a tibial tray or a liner for an acetabular cup. The finished part is then sealed into a package in an oxygen reduced atmosphere. The package is of an airtight nature to prevent oxygen or moisture from entering after the package is sealed. The then packaged implant is radiation sterilized and then heat treated for the predetermined time and temperature sufficient to form cross-links between free radicals of the neighboring polymeric chains. This prevents further oxidation once the implant is removed from the package.
  • [0023]
    In general, the implant is heated for at least 48 hours at a temperature of about 37° C. to about 70° C. and preferably for 144 hours at 50° C.
  • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • [0024]
    In the preferred method, a raw polymeric material such as UHMWPE is obtained by, for example, ram extrusion, compression molding, or other forming processes. These methods use virgin polymer powder as a starting material.
  • [0025]
    However, virgin polymer resin powder may contain air or moisture, which may exist in the resin micro-structure or simply deposited on the resin surfaces. If air or moisture is not removed from resin powder prior to the forming process, it can be trapped in the plastic matrix after forming and cannot escape. This is true even with the use of vacuum or gas flushing techniques. During the sterilization radiation process, the trapped air or moisture or both will react with free radicals generated in the plastic to cause oxidation. The trapped moisture can also absorb radiation energy and dissociate into oxygen and hydroxyl free radicals which will also react with the plastic to cause oxidation. Therefore, by removing air and moisture prior to the forming process, oxidation during sterilization radiation can be avoided.
  • [0026]
    The preferred method for eliminating air and moisture is to apply a vacuum of less than 3″ of mercury (76 torr) to the polymer resin for a prescribed time to reduce the levels of air and moisture to a minimal or acceptable value. The level for oxygen is preferably 0.5% (volume by volume and no more than 1%). The moisture level is preferably 10% of relative humidity (and no more than 20% relative humidity). Then sufficient amounts of deoxidizing agents, such as oxygen absorbents and moisture desiccants, are placed together with the polymer resin in a sealed container to reduce the levels of air and moisture to the minimal or acceptable value. An example of an oxygen absorbent is AGELESS® which is an iron oxide compound and commercially available from Cryovac Division, W. R. Grace & Co., Duncan, S.C. An example of moisture desiccant is silica gel which is commercially available. These materials are placed with the resin in the sealed container for approximately 10 hours. Alternately, or in combination, an inert gas, such as nitrogen, argon, helium or neon is used to flush the container, holding the polymer resin powder, until the levels of air and moisture are reduced to the accepted value. Of course, any combination of the above methods can also be used.
  • [0027]
    In order to ensure a raw material for an orthopedic implant with no oxygen, not only must the UHMWPE resin powder be free of air and moisture, but the entire forming operation of, for example, ram extrusion, compression molding, or other forming process should be carried out in an inert or low oxygen atmosphere as well. During the forming process, due to high temperature and high pressure applied in the process, UHMWPE polymer chains may be broken to generate free radicals and cross-links. While cross-links generated in the forming process have no adverse effects on material properties, the free radicals produced, as described above, can react with air or other oxidants. Therefore, it is important to maintain the inert atmosphere during the forming process to minimize oxidation.
  • [0028]
    Any free radicals generated should be eliminated as soon as the forming process is completed by annealing. If the formed UHMWPE contains free radicals and is exposed to air or other oxidants after the forming process, oxidation will occur. The polymer should be annealed at an elevated temperature in an inert atmosphere for a prescribed time. This is because the rate of free radical reactions (reactions 10 through 12) increases with increasing temperature, according to the following general expressions: r t = k 1 [ r ] and P t = k 2 [ P ] ( 13 )
  • [0029]
    Compared to room temperature, an elevated temperature not only increases the reaction rate constants, k1 and k2, but also helps free radicals r˜and P. to migrate in the plastic matrix to meet other neighboring free radicals for cross-linking reactions. In general, the desired elevated temperature is between the room temperature and the melting point of the polymer. For UHMWPE, this temperature range is between about 25° C. and about 140° C. However, the preferred annealing temperature range is from about 37° C. to about 135° C. The preferred time and temperature is 130° C. for 20 hours with the minimum annealing time being about 4 hours (requiring a temperature at the high end of the range). It is to be noted that the higher the temperature used, the shorter the time period needed to combine free radicals. Additionally, due to the high viscosity of a UHMWPE melt, the formed UHMWPE often contains residual (internal) stress caused by incomplete relaxation during the cooling process, which is the last step of the forming process. The annealing process described herein will also help to eliminate or reduce the residual stress. A residual stress contained in a plastic matrix can cause dimensional instability and is in general undesirable.
  • [0030]
    In applications such as for orthopedic implants, the formed UHMWPE is further machined into desired shapes. In general, the machining is done at room temperature and no damage to the plastic will occur. However, certain machine tools, when operated at a high speed, may generate local heat and cause thermal breakdown of UHMWPE polymer chains. In this case, the above described annealing process may be employed to eliminate any newly formed free radicals prior to packaging.
  • [0031]
    After machining, the polymeric component is packaged in an air tight package in an oxidant-free atmosphere. Thus, all air and moisture must be removed from the package prior to the sealing step. Machines to accomplish this are commercially available, such as from Orics Industries Inc., College Point, N.Y., which flush the package with a chosen inert gas, vacuum the container, flush the container for the second time, and then heat seal the container with a lid. In general, less than 0.5% (volume by volume) oxygen concentration can be obtained consistently. An example of a suitable oxidant impermeable (air tight) packaging material is polyethylene terephthalate (PET). Other examples of oxidant impermeable packaging material is poly(ethylene vinyl alcohol) and aluminum foil, whose oxygen and water vapor transmission rates are essentially zero. All these materials are commercially available. Several other suitable commercial packaging materials utilize a layer structure to form a composite material with superior oxygen and moisture barrier properties. An example of this type is a layered composite comprised of polypropylene/poly(ethylene vinyl alcohol)/polypropylene.
  • [0032]
    In general, the sterilization radiation step for the packaged implant may take a few hours to complete. As described above, it is imperative that during this time period, the transmission of oxidants, such as oxygen and moisture, into the package be kept to a minimal or at an acceptable value to avoid oxidation.
  • [0033]
    Following sterilization radiation, a heat treatment step should be performed in an inert atmosphere and at an elevated temperature to cause free radicals to form cross-links without oxidation. If proper packaging materials and processes are used and oxidant transmission rates are minimal, then the oxidant-free atmosphere can be maintained in the package and a regular oven with air circulation can be used for heat treatment after sterilization. To absolutely ensure that no oxidants leak into the package, the oven may be operated under a vacuum or purged with an inert gas. In general, if a higher temperature is used, a shorter time period is required to achieve a prescribed level of oxidation resistance and cross-linking. In many cases, the relationship between the reaction temperature and the reaction rate follows the well-known Arrhennius equation:
    k 1 or k2 =A* exp (−▴H/T)  (14)
    where k1 and k2 are reaction rate constants from reactions 13 and 14
  • [0035]
    A is a reaction dependent constant
  • [0036]
    ▴H is activation energy of reaction
  • [0037]
    T is absolute temperature (K)
  • [0038]
    However, the temperature should not exceed the distortion temperature of either the packaging material or the plastic components. For UHMWPE, the temperature range is between about 25° C. and about 140° C. However, considering the distortion of the packaging material, the preferred temperature is 37° C. to 70° C.
  • [0039]
    It is very important to ensure that the number of free radicals has been reduced to a minimal or an accepted level by the heat treatment. This is because the presence of an oxidant causes not only the oxidation of pre-existing free radicals, but also the formation of new free radicals via reactions 2 through 7. When the number of free radicals grows, the extent of oxidation and the oxidation rate will increase according to the following equations: r t = k 3 [ r ] [ O 2 ] and P t = k 4 [ P ] [ O 2 ] ( 15 )
  • [0040]
    Where free radicals r. and P. can grow in number in the presence of oxidants and in turn increase the oxidation rates. It is also to be noted that the oxidation reaction rate constants k3 and k4 increase with increasing temperature, similar to k1 and k2. Therefore, to determine if a certain level of residual free radicals is acceptable or not, it is required to evaluate specific material properties after the plastic sample is stored or aged at the application temperature for a time period which is equal to or longer than the time period intended for the application of the plastic component. An alternative to the method to assess the aging effect is to raise the aging temperature of the plastic sample for a shorter time period. This will increase the reaction rate constants k3 and k4 significantly and shorten the aging time. It has been found that an acceptable level of residual free radicals is 1.0×1017g for UHMWPE use for orthopedic implants.
  • [0041]
    After heat treatment, the irradiated packaged plastic component is now ready to use. The package can be opened and exposed to air or moisture without causing oxidation. The oxidation resistance of the sterilized plastic component to other oxidants is similar to that of the virgin, unirradiated polymer.
  • [0042]
    Sample Preparation
  • [0043]
    A surgical grade UHMWPE rod produced by ram extrusion was machined into samples of desirable shapes. Four sets of samples were prepared using these machined samples by the following methods:
  • [0044]
    Method A: a UHMWPE sample as machined and unirradiated.
  • [0045]
    Method B: A UHMWPE sample was heat sealed in a glycol-modified polyethylene terephthalate (PETG, made by Eastman Plastics, Inc., Kingsport, Tenn.) blister in air with an aluminum lid of 0.1 mm in thickness. The sealed blister containing the UHMWPE sheet was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The package was then opened and exposed to room air.
  • [0046]
    Method C: A UHMWPE sample was placed in a PETG blister and heat sealed in dry nitrogen with an aluminum lid of 0.1 mm in thickness by the Orics Vacuum Gas Flush Heat Seal Machine (Model SLS-VGF-100M for modified atmosphere packaging, made by Orics Industries Inc., College Point, N.Y.) which went through the following cycles:
      • i) nitrogen gas (moisture-free) flush for five seconds
      • ii) vacuum to a pressure of equal to or below 3 inches of mercury
      • iii) nitrogen gas flush (moisture-free) for five seconds
      • iv) heat seal
  • [0051]
    The oxygen concentration in the sealed blister was measured by a Mocon Oxygen Analyzer to be 0.325% (volume by volume). The sealed blister containing the UHMWPE sample was sterilized by irradiation of gamma-rays in a dose of 2.5 Mrad. The oxygen concentration in the sealed blister after sterilization radiation was measured to be 0.350%. The package was then opened and exposed to room air.
  • [0052]
    Method D: Same as Method C, except that after gamma-ray irradiation, the sealed blister containing the UHMWPE sample was heat treated at 50° C. for 144 hours in an oven, then transferred from the oven to room temperature for cooling. After the package was cooled to room temperature, the oxygen concentration was measured by a Mocon Oxygen Analyzer to be 0.360%. The package was then opened and exposed to room air.
  • [0053]
    Samples prepared by the above methods were used in the following examples for evaluation.
  • EXAMPLE 1
  • [0054]
    Two sets of 1-mm-thick UHMWPE sheets prepared by Methods A through D above were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, a thin film specimen of about 100 microns in thickness was cut from each of the 1-mm-thick aged UHMWPE sheets and placed in an IR window for a standard FTIR (A Nicolet 710 FTIR system was used) transmission run. A total of 32 spectra (scans) was collected and averaged. To determine the extent of oxidation, the IR absorption peaks in the frequency range of between 1660 and 1800 cm−1, corresponding to carbonyl (C—O) functional groups, were integrated for the peak area. The peak area is proportional to the amount of oxidized UHMWPE in the specimen. To correct for difference in specimen thickness, the integrated peak area was then normalized to the specimen thickness, by dividing by the area of the 1463 cm−1 (methyl) peak which is proportional to the specimen thickness. The obtained ratio was defined as oxidation index. A third set of 1-mm-thick UHMWPE sheets prepared by methods A through D, but without oven aging, was also evaluated by the same FTIR method for comparison. Oxidation indices obtained are shown in Table 1:
    TABLE 1
    Sample Oxidation Index
    Method A/not oven aged ca. 0.
    Method A/11 day oven aging ca. 0.
    Method A/23 day oven aging ca. 0.
    Method B/not oven aged 0.02
    Method B/11 day oven aging 0.06
    Method B/23 day oven aging 0.11
    Method C/not oven aged 0.01
    Method C/11 day oven aging 0.04
    Method C/23 day oven aging 0.08
    Method D/not oven aged 0.01
    Method D/11 day oven aging 0.01
    Method D/23 day oven aging 0.01
  • [0055]
    From Table 1 results, it can be seen that the unirradiated UHMWPE sample (Method A) was free of oxidation (below the ETIR detectable level), even after 23 days of oven aging in air at 80° C. On the other hand, the UHMWPE sample irradiated in air (Method B) showed considerable oxidation and the extent of oxidation (as indicated by the oxidation index) increased with increasing aging time. After 23 days of oven aging, the oxidation index reached 0.11. For the UHMWPE sample irradiated in nitrogen (Method C), the initial oxidation index before oven aging was 0.01 which was not significant. However, during the oven aging, the oxidation index increased to 0.04 for 11 days and 0.08 for 23 days respectively. The results indicate that while irradiation in an inert atmosphere is an improvement over oxidation in air, the irradiated plastic component will oxidize further over time once it is exposed to air or other oxidants. In contrast, the UHMWPE sample irradiated in nitrogen followed by heat treatment at 50° C. for 144 hours (Method D), showed an initial oxidation index of only 0.01 which did not increase after 11 or 23 days of oven aging, indicating that this sample has superior oxidation resistance than the samples prepared by Method B or C.
  • EXAMPLE 2
  • [0056]
    Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, six tensile specimens with a dumbbell shape according to ASTM D638 (Type IV) were cut from each of the 1-mm-thick aged UHMWPE sheets. A standard tensile test was performed for each specimen at a speed of 2 inches/mm. Another set of 1-mm-thick UHMWPE sheets prepared by Methods B through D cited in the Sample Preparation, but without oven aging, were also evaluated by the same tensile test method for comparison. Tensile breaking strength results (average of six tests for each condition) are shown in Table 2:
    TABLE 2
    Tensile Breaking
    Sample Strength, psi
    Method B/not oven aged 6510
    Method B/11 day oven aging 5227
    Method B/23 day oven aging 3192
    Method C/not oven aged 6875
    Method C/11 day oven aging 6400
    Method C/23 day oven aging 6004
    Method D/not oven aged 6941
    Method D/11 day oven aging 7113
    Method D/23 day oven aging 6904
  • [0057]
    From Table 2, tensile breaking strength shows the most deterioration for the sample irradiated in air (Method B). The sample irradiated in nitrogen (Method C) shows some improvement over the sample prepared by Method B. However, the decrease in tensile breaking strength upon oven aging still occurs. In contrast, the sample irradiated in nitrogen followed by heat treatment (50° C. for 144 hours, Method D), shows no change in tensile breaking strength, indicating a superior oxidation resistance.
  • EXAMPLE 3
  • [0058]
    Two sets of 1-mm-thick UHMWPE sheets prepared by Methods B and Method D cited in the Sample Preparation were oven aged in air at 80° C. for 11 and 23 days respectively. After these sheets were cooled in room temperature, samples cut from sheets were characterized by a high temperature gel permeation chromatograph (GPC) column for molecular weight distribution. The samples were dissolved in hot trichlorobenzene (TCB). They were then run in the aforementioned solvent at 1.2 ml/mm. using a Jordi Gel Mixed Bed Column, 50 cm×10.0 mm ID., at a column oven temperature of 145° C. on the Waters 15° C. Chromatograph. The injection size was 250 uL of a 0.1% solution. An antioxidant (N-phenyl-2-naphthylamine) was added to all high temperature GPC samples to prevent polymer deterioration.
  • [0059]
    Prior to sample runs, the column was calibrated using narrow MW polystyrene standards. Since the samples were only partially soluble in the solvent due to cross-linking, the so-determined molecular weight distribution was for the soluble portion only. To determine the extent of cross-linking (solubility), a two hundred milligram sample cut from sheets were dissolved in 100 cc of 1,2,4-trichlorobenzene. Each sample was then heated to approximately 170° C. with N-phenyl-2-naphthyla-mine antioxidant added for 6 hours. The samples were then hot filtered at approximately 170° C. using separate preweighed high temperature filters for each sample.
  • [0060]
    After filtration, the filters were cooled to room temperature and washed individually with dichloromethane. They were then placed in a convection oven at 105° C. for 6 hours to dry and then reweighed. The weight fraction of the undissolved (cross-linked) portion was then determined based upon the initial weight of 200 mg. To determine the low molecular weight fraction present in each sample, the weight fraction of molecular weight below 105 in the soluble portion, determined by GPC, was multiplied by the percent solubility to give weight percent of low molecular weight fraction in each sample. Results are shown in Table 3:
    TABLE 3
    Weight
    Percent Of Weight
    Soluble Percent Percent Of
    Portion Solubility In Entire Sample
    Sample Below 105 Solvent Below 105
    Method 28.0 98.2 27.5
    B/without
    oven aging
    Method B/11 36.2 100.0 36.2
    day oven
    aging
    Method B/23 48.1 100.0 48.1
    day oven
    aging
    Method 22.7 80.9 18.4
    D/without
    oven aging
    Method D/11 20.5 73.6 15.1
    day oven
    aging
    Method D/23 24.2 74.7 18.1
    day oven
    aging
  • [0061]
    From Table 3, it can be seen that the sample made by Method D contains more cross-linking (i.e., less soluble) than one made by Method B. Upon oven aging, the low molecular weight fraction (defined as below 105) in the sample made by Method B increases from 0.275 to 0.481 while that of the sample made by Method D remains virtually unchanged at about 0.18 after 23 days of oven aging. The increase in low molecular weight fraction was due to chain scission caused by oxidative reactions. The results indicate that the process of method D can produce an irradiated polymer with a superior oxidation resistance.
  • EXAMPLE 4
  • [0062]
    UHMWPE samples of 0.5 inch cubes prepared by Methods B and Method D cited in the Sample Preparation were evaluated for deformation under load (creep resistance). Testing procedures according to ASTM D 621 (A) (24 hr/23° C./1000 psi/90 mm recovery) were used. Results are summarized in Table 4:
    TABLE 4
    Sample Deformation Under Load %
    Method B 0.80
    Method D 0.60
  • [0063]
    From Table 4, it is concluded that the sample prepared by Method D, the invention, possesses a superior creep resistance (0.6%) to one prepared by Method B(0.8%).
  • EXAMPLE 5
  • [0064]
    Two 1-mm-thick UHMWPE samples were annealed in an oven filled with air and dry nitrogen (oxygen concentration is below 0.2%) respectively at 130° C. for 20 hours in order to remove residual stress on the samples. After the sheets were cooled to room temperature in the oven, they were removed from the oven and cut into dumbbell shaped tensile specimens (ASTM D 638, Type V) for evaluation. A standard tensile test according to ASTM D 638 was performed at a speed of 2 inches/min for each of six specimens annealed in air and in dry nitrogen respectively. Results are shown in Table 5:
    TABLE 5
    TYS, TBS, Toughness,
    Sample EAB, % psi psi lbs-in/in3
    Air 414 3547 6257 10,210
    annealed
    Nitrogen 485 3517 8917 18,960
    annealed

    Note:

    EAB—elongation at break

    TYS—tensile yield strength

    TBS—Tensile breaking strength
  • [0065]
    From the above table, it is seen that the sample annealed in nitrogen exhibits a higher elongation at break, a higher tensile breaking strength, and a higher toughness, compared to one annealed in air, while the tensile yield strength is similar between the two samples. The results indicate that the sample annealed in nitrogen is more ductile than the one annealed in air. The loss of ductility in the sample annealed in air is due to oxidative chain scission.
  • [0066]
    To determine oxidation indices in these two samples, a thin film specimen of ca. 100 microns in thickness was cut from each of the 1-mm-thick annealed UHMWPE sheets and placed in an IR window for a standard FTIR (a Nicolet 710 FTIR 10 system was used) transmission run, using the procedures and calculations employed in the Sample Preparation. Oxidation indices obtained are shown in Table 6.
    TABLE 6
    Sample Oxidation Index
    Air Annealed 0.10
    Nitrogen Annealed ca. 0.0
  • [0067]
    From the above results, it is seen that the UHMWPE sample annealed in air after ram extrusion showed significant oxidation due to free radicals generated in the forming process. In contrast, the UHMWPE sample annealed in nitrogen showed no oxidation (below the FTIR detectable level). It is concluded that annealing in nitrogen can prevent the polymer from oxidation and produce a polymer with superior ductility.
  • [0068]
    While several examples of the present invention have been described, it is obvious that many changes and modifications may be made thereunto, without departing from the spirit and scope of the invention.
  • [0069]
    Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2904480 *Jun 6, 1955Sep 15, 1959Grace W R & CoPolyethylene
US3022543 *Feb 7, 1958Feb 27, 1962Grace W R & CoMethod of producing film having improved shrink energy
US3057791 *Jul 6, 1959Oct 9, 1962Phillips Petroleum CoRadiation curing of polymers
US3090770 *Apr 26, 1960May 21, 1963Grace W R & CoBlended polyethylene compositions of improved clarity and method of making same
US3162623 *Dec 26, 1961Dec 22, 1964Du PontCrosslinking of polymers with nitrogen fluorides
US3297641 *Jan 17, 1964Jan 10, 1967Grace W R & CoProcess for cross-linking polyethylene
US3330748 *Jan 11, 1955Jul 11, 1967Gen ElectricMethod and apparatus for irradiating organic polymers with electrons
US3352818 *Jan 26, 1965Nov 14, 1967Glanzstoff AgStability of polyolefines
US3362897 *Nov 21, 1962Jan 9, 1968Gen ElectricStable irradiated polyethylene
US3563869 *Nov 5, 1957Feb 16, 1971Grace W R & CoIrradiated polyethylene
US3616365 *Sep 22, 1969Oct 26, 1971Basf AgProcess of making particulate expanded olefin polymers having high thermal stability
US3758273 *Apr 1, 1971Sep 11, 1973Gillette CoProcesses for sterilizing polypropylene objects
US3832827 *Jul 10, 1972Sep 3, 1974J LemelsonContainer forming and filling apparatus
US3886056 *Nov 1, 1972May 27, 1975Ryozo KitamaruProcess for producing a high melting temperature polyethylene employing irradiation and orienting
US4226905 *Apr 16, 1979Oct 7, 1980Du Pont Canada Inc.Manufacture of film from partially crosslinked polyethylene
US4587163 *Nov 1, 1984May 6, 1986Zachariades Anagnostis EPreparation of ultra high molecular weight polyethylene morphologies of totally fused particles with superior mechanical performance
US4655769 *Dec 18, 1985Apr 7, 1987Zachariades Anagnostis EUltra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US4701288 *Jun 5, 1985Oct 20, 1987Bausch & Lomb IncorporatedMethod of making articles of dissimilar polymer compositions
US4813210 *Oct 1, 1987Mar 21, 1989Nissho CorporationRadiation-sterilized, packaged medical device
US4820466 *Jan 22, 1987Apr 11, 1989Zachariades Anagnostis EProcess for obtaining ultra-high modulus products
US4832965 *May 16, 1986May 23, 1989Helin Stig AakeMethod of making a bottle and packaging a water ration therein
US4950151 *Jan 19, 1989Aug 21, 1990Zachariades Anagnostic ERolling die for producing high modulus products
US5030402 *Mar 17, 1989Jul 9, 1991Zachariades Anagnostis EProcess for producing a new class of ultra-high-molecular-weight polyethylene orthopaedic prostheses with enhanced mechanical properties
US5037928 *Mar 23, 1990Aug 6, 1991E. I. Du Pont De Nemours And CompanyProcess of manufacturing ultrahigh molecular weight linear polyethylene shaped articles
US5047446 *Jul 22, 1988Sep 10, 1991Himont IncorporatedThermal treatment of irradiated propylene polymer material
US5096654 *Jul 13, 1989Mar 17, 1992The National Research And Development CorporationSolid phase deformation process
US5153039 *Dec 9, 1991Oct 6, 1992Paxon Polymer Company, L.P.High density polyethylene article with oxygen barrier properties
US5160464 *Mar 8, 1988Nov 3, 1992National Research Development CorporationPolymer irradiation
US5160677 *May 13, 1991Nov 3, 1992United States Surgical CorporationPressurized powder support for treating processes
US5200439 *Apr 2, 1991Apr 6, 1993Mitsui Toatsu Chemicals, Inc.Method for increasing intrinsic viscosity of syndiotactic polypropylene
US5352732 *Dec 29, 1992Oct 4, 1994E. I. Du Pont De Nemours And CompanyHomogeneous, high modulus ultrahigh molecular weight polyethylene composites and processes for the preparation thereof
US5428079 *Jul 30, 1991Jun 27, 1995Dsm N.V.Solution of ultra-high molecular weight polyethylene
US5466530 *Jan 21, 1993Nov 14, 1995England; Garry L.Biocompatible components fabricated from a substantially consolidated stock of material
US5508319 *Aug 19, 1994Apr 16, 1996Montell North America Inc.High melt strength, ethylene polymer, process for making it, and use thereof
US5543471 *Mar 15, 1995Aug 6, 1996Howmedica Inc.Non-oxidizing polymeric medical implant
US5552104 *Apr 13, 1995Sep 3, 1996Montell North America Inc.High melt strength, ethylene polymer, process for making it, and use thereof
US5577368 *Apr 3, 1995Nov 26, 1996Johnson & Johnson Professional, Inc.Method for improving wear resistance of polymeric bioimplantable components
US5728748 *Oct 16, 1996Mar 17, 1998Howmedica Inc.Non oxidizing polymeric medical implant
US5753182 *Feb 14, 1996May 19, 1998Biomet, Inc.Method for reducing the number of free radicals present in ultrahigh molecular weight polyethylene orthopedic components
US5874123 *Jan 24, 1997Feb 23, 1999Park; Joon B.Precoated polymeric prosthesis and process for making same
US5879400 *Feb 13, 1996Mar 9, 1999Massachusetts Institute Of TechnologyMelt-irradiated ultra high molecular weight polyethylene prosthetic devices
US6017975 *Aug 15, 1997Jan 25, 2000Saum; Kenneth AshleyProcess for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6143232 *Jul 29, 1999Nov 7, 2000Bristol-Meyers Squibb CompanyMethod of manufacturing an articulating bearing surface for an orthopaedic implant
US6168626 *Sep 18, 1995Jan 2, 2001Bmg IncorporatedUltra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
US6174934 *Jan 23, 1998Jan 16, 2001Stryker Technologies CorporationNon-oxidizing polymeric medical implant
US6184265 *Jul 29, 1999Feb 6, 2001Depuy Orthopaedics, Inc.Low temperature pressure stabilization of implant component
US6228900 *Jul 8, 1997May 8, 2001The Orthopaedic Hospital And University Of Southern CaliforniaCrosslinking of polyethylene for low wear using radiation and thermal treatments
US6272814 *Jul 25, 2000Aug 14, 2001Wakai & Co., Ltd.Method of packaging nut assemblies
US6281264 *Sep 27, 1999Aug 28, 2001The Orthopaedic HospitalChemically crosslinked ultrahigh molecular weight polyethylene for artificial human joints
US6395799 *Feb 21, 2000May 28, 2002Smith & Nephew, Inc.Electromagnetic and mechanical wave energy treatments of UHMWPE
US6432349 *Jun 29, 1999Aug 13, 2002Zimmer, Inc.Process of making an articulating bearing surface
US6494917 *Oct 6, 2000Dec 17, 2002Orthopaedic HospitalWear resistant surface-gradient crosslinked polyethylene
US6503439 *Jun 15, 2000Jan 7, 2003Albert H. BursteinProcess for forming shaped articles of ultra high molecular weight polyethylene suitable for use as a prosthetic device or a component thereof
US6547828 *Feb 23, 2001Apr 15, 2003Smith & Nephew, Inc.Cross-linked ultra-high molecular weight polyethylene for medical implant use
US6562540 *Oct 29, 2001May 13, 2003Depuy Orthopaedics, Inc.Process for medical implant of cross-linked ultrahigh molecular weight polyethylene having improved balance of wear properties and oxidation resistance
US6641617 *Dec 3, 1999Nov 4, 2003The General Hospital Corp.Radiation and melt treated ultra high molecular weight polyethylene prosthetic device and method
US6664308 *Jan 8, 2002Dec 16, 2003Stryker Technologies CorporationNon-oxidizing polymeric medical implant
US6818020 *Jun 13, 2003Nov 16, 2004Howmedica Osteonics Corp.Non-oxidizing polymeric medical implant
US20020013781 *Jan 12, 2001Jan 31, 2002Erik PetersenSystem and method of searchin and gathering information on-line and off-line
US20020107299 *Jan 8, 2002Aug 8, 2002Deh-Chuan SunNon-oxidizing polymeric medical implant
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7780896Dec 4, 2008Aug 24, 2010Biomet Manufacturing Corp.Crosslinked polymeric material with enhanced strength and process for manufacturing
US7846376Aug 18, 2006Dec 7, 2010Zimmer GmbhUltra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US7858671Jul 29, 2004Dec 28, 2010The General Hospital CorporationRadiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US7863348Oct 31, 2008Jan 4, 2011Zimmer GmbhUltra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US7927536Aug 3, 2010Apr 19, 2011Biomet Manufacturing Corp.Solid state deformation processing of crosslinked high molecular weight polymeric materials
US7993401Feb 21, 2008Aug 9, 2011Biomet Manufacturing Corp.Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8128703Nov 17, 2009Mar 6, 2012Depuy Products, Inc.Fixed-bearing knee prosthesis having interchangeable components
US8129440 *Oct 14, 2009Mar 6, 2012Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8137608Aug 3, 2010Mar 20, 2012Biomet Manufacturing Corp.Crosslinked polymeric material with enhanced strength and process for manufacturing
US8178594Dec 14, 2010May 15, 2012Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8187335Jun 30, 2008May 29, 2012Depuy Products, Inc.Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US8192498Jun 30, 2008Jun 5, 2012Depuy Products, Inc.Posterior cructiate-retaining orthopaedic knee prosthesis having controlled condylar curvature
US8206451Jun 30, 2008Jun 26, 2012Depuy Products, Inc.Posterior stabilized orthopaedic prosthesis
US8236061Jun 19, 2009Aug 7, 2012Depuy Products, Inc.Orthopaedic knee prosthesis having controlled condylar curvature
US8262976May 22, 2009Sep 11, 2012Biomet Manufacturing Corp.Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8263676Dec 23, 2010Sep 11, 2012The General Hospital CorporationRadiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US8398913Jul 18, 2011Mar 19, 2013Biomet Manufacturing Corp.Solid state deformation processing of crosslinked high molecular weight polymeric materials
US8399535Jun 10, 2010Mar 19, 2013Zimmer, Inc.Polymer [[s]] compositions including an antioxidant
US8470903Nov 9, 2010Jun 25, 2013Zimmer GmbhUltra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US8563623Dec 8, 2004Oct 22, 2013The General Hospital CorporationRadiation melt treated ultra high molecular weight polyethylene prosthetic devices
US8641959Jul 24, 2008Feb 4, 2014Biomet Manufacturing, LlcAntioxidant doping of crosslinked polymers to form non-eluting bearing components
US8652212Jan 29, 2009Feb 18, 2014Zimmer, Inc.Orthopedic component of low stiffness
US8664290Jul 30, 2010Mar 4, 2014Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8669299Feb 23, 2012Mar 11, 2014Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US8673202Nov 10, 2010Mar 18, 2014Zimmer, GmbhUltra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US8734522Jun 20, 2012May 27, 2014Depuy (Ireland)Posterior stabilized orthopaedic prosthesis
US8784496Jun 4, 2012Jul 22, 2014Depuy (Ireland)Orthopaedic knee prosthesis having controlled condylar curvature
US8795380Jul 2, 2012Aug 5, 2014Depuy (Ireland)Orthopaedic knee prosthesis having controlled condylar curvature
US8828086Jun 30, 2008Sep 9, 2014Depuy (Ireland)Orthopaedic femoral component having controlled condylar curvature
US8834575May 28, 2012Sep 16, 2014Depuy (Ireland)Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US8865788Jan 19, 2001Oct 21, 2014The General Hospital CorporationRadiation and melt treated ultra high molecular weight polyethylene prosthetic devices
US9011547Jan 21, 2010Apr 21, 2015Depuy (Ireland)Knee prosthesis system
US9017590Mar 5, 2013Apr 28, 2015Biomet Manufacturing, LlcSolid state deformation processing of crosslinked high molecular weight polymeric materials
US9119723Jun 27, 2012Sep 1, 2015Depuy (Ireland)Posterior stabilized orthopaedic prosthesis assembly
US9168145Jun 27, 2012Oct 27, 2015Depuy (Ireland)Posterior stabilized orthopaedic knee prosthesis having controlled condylar curvature
US9204967Mar 7, 2013Dec 8, 2015Depuy (Ireland)Fixed-bearing knee prosthesis having interchangeable components
US9204968Apr 21, 2014Dec 8, 2015Depuy (Ireland)Posterior stabilized orthopaedic prosthesis
US9220601Aug 6, 2014Dec 29, 2015Depuy (Ireland)Orthopaedic femoral component having controlled condylar curvature
US9238719 *Nov 6, 2008Jan 19, 2016Dsm Ip Assets B.V.Process for producing high molecular weight polyethylene
US9265545Jan 17, 2014Feb 23, 2016Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US9277949Jan 17, 2014Mar 8, 2016Zimmer, Inc.Antioxidant stabilized crosslinked ultra high molecular weight polyethylene for medical device applications
US9290629 *Mar 27, 2015Mar 22, 2016Dsm Ip Assets B.V.Process for producing high molecular weight polyethylene
US9326864Sep 15, 2014May 3, 2016Depuy (Ireland)Orthopaedic knee prosthesis having controlled condylar curvature
US9398956Mar 7, 2013Jul 26, 2016Depuy (Ireland)Fixed-bearing knee prosthesis having interchangeable components
US9421104Feb 3, 2014Aug 23, 2016Biomet Manufacturing, LlcAntioxidant doping of crosslinked polymers to form non-eluting bearing components
US9452053May 5, 2014Sep 27, 2016Depuy (Ireland)Orthopaedic knee prosthesis having controlled condylar curvature
US9492280May 13, 2014Nov 15, 2016Medidea, LlcMultiple-cam, posterior-stabilized knee prosthesis
US9539099Jun 19, 2014Jan 10, 2017Depuy Ireland Unlimited CompanyOrthopaedic knee prosthesis having controlled condylar curvature
US9555160 *Feb 19, 2016Jan 31, 2017Dsm Ip Assets B.V.Process for producing high molecular weight polyethylene
US9586370Oct 11, 2013Mar 7, 2017Biomet Manufacturing, LlcMethod for making ultra high molecular weight polyethylene
US9708467Sep 30, 2014Jul 18, 2017Zimmer, Inc.Polymer compositions comprising one or more protected antioxidants
US9718241Jan 16, 2014Aug 1, 2017Zimmer, Inc.Method of manufacturing an acetabular component
US20060079595 *Oct 13, 2004Apr 13, 2006Schroeder David WSolid state deformation processing of crosslinked high molecular weight polymeric materials
US20060079596 *Oct 13, 2004Apr 13, 2006Schroeder David WCrosslinked polymeric material with enhanced strength and process for manufacturing
US20060280644 *Jun 1, 2006Dec 14, 2006Scott SellersMethod for terminal sterilization of transdermal delivery devices
US20060280645 *Jun 1, 2006Dec 14, 2006Scott SellersMethod for terminal sterilization of transdermal delivery devices
US20070059334 *Aug 18, 2006Mar 15, 2007Zimmer Technology, Inc.Ultra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US20090030524 *Jul 24, 2008Jan 29, 2009Biomet Manufacturing Corp.Antioxidant doping of crosslinked polymers to form non-eluting bearing components
US20090082546 *Dec 4, 2008Mar 26, 2009Biomet Manufacturing Corp.Crosslinked polymeric material with enhanced strength and process for manufacturing
US20090118390 *Oct 31, 2008May 7, 2009Abt Niels AUltra high molecular weight polyethylene articles and methods of forming ultra high molecular weight polyethylene articles
US20090212343 *Apr 2, 2009Aug 27, 2009Actel CorporationNon-volatile two-transistor programmable logic cell and array layout
US20100029858 *Oct 14, 2009Feb 4, 2010Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20100137481 *Nov 19, 2009Jun 3, 2010Zimmer GmbhPolyethylene materials
US20100298945 *Aug 3, 2010Nov 25, 2010Biomet Manufacturing Corp.Crosslinked polymeric material with enhanced strength and process for manufacturing
US20100314800 *Aug 3, 2010Dec 16, 2010Biomet Manufacturing CorporationSolid state deformation processing of crosslinked high molecular weight polymeric materials
US20100331995 *Nov 6, 2008Dec 30, 2010Harold Jan SmeltProcess for producing high molecular weight polyethylene
US20110028600 *Jul 30, 2010Feb 3, 2011Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20110133371 *Dec 14, 2010Jun 9, 2011Zimmer, Inc.Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
US20110135917 *Nov 10, 2010Jun 9, 2011Zimmer GmbhUltra High Molecular Weight Polyethylene Articles And Methods Of Forming Ultra High Molecular Weight Polyethylene Articles
US20110178605 *Jan 21, 2010Jul 21, 2011Depuy Products, Inc.Knee prosthesis system
US20150203641 *Mar 27, 2015Jul 23, 2015Dsm Ip Assets B.V.Process for producing high molecular weight polyethylene
US20160184476 *Feb 19, 2016Jun 30, 2016Dsm Ip Assets B.V.Process for producing high molecular weight polyethylene
USRE44762Sep 18, 1995Feb 11, 2014Bmg IncorporatedUltra high molecular weight polyethylene molded article for artificial joints and method of preparing the same
WO2009060043A2 *Nov 6, 2008May 14, 2009Dsm Ip Assets BvProcess for producing high molecular weight polyethylene
WO2009060043A3 *Nov 6, 2008Aug 27, 2009Dsm Ip Assets BvProcess for producing high molecular weight polyethylene
Classifications
U.S. Classification522/161
International ClassificationA61L27/00, C08F2/46, A61L15/60, A61L31/00, A61L33/00, A61L31/04, A61L29/04, B29C43/00, A61L27/16, B29C43/16, B29C35/08, A61L2/08
Cooperative ClassificationY10S522/915, Y10S525/937, Y10S623/901, B29K2105/253, A61L2/087, A61L15/60, A61L2/082, B29C35/0805, A61L27/16, A61L31/048, A61L2/08, A61L29/041, A61L2/081, B29L2031/7532, B29K2995/0089, B29C43/00, B29K2023/0683, B29C43/16, B29K2995/0087, B29C2035/085
European ClassificationA61L31/04H, A61L29/04B, A61L27/16, A61L15/60, A61L2/08B, A61L2/08J, A61L2/08D, A61L2/08
Legal Events
DateCodeEventDescription
Nov 18, 2004ASAssignment
Owner name: HOWMEDICA OSTEONICS CORP., NEW JERSEY
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUN, DEH-CHUAN;STARK, CASPER F.;REEL/FRAME:015391/0613;SIGNING DATES FROM 20041107 TO 20041112